Results 21 to 30 of about 296,469 (371)

Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis

Brazilian Journal of Infectious Diseases, 2013
Background/aims: Controversial results have been found in literature for the association between insulin resistance and sustained virologic response to standard chronic hepatitis C treatment. This study aims to provide a systematic literature review with
Marcela Pezzoto Laurito, Edison Roberto Parise   +1 more
doaj   +3 more sources

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Journal of Medical Case Reports, 2020
Background Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after achieving sustained ...
Ken Kurokawa, Takamasa Ohki, Jun Kato, Yukiyo Fukumura, Makoto Imai, Chikako Shibata, Junya Arai, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Michiharu Seki, Masaya Mori, Nobuo Toda, Kazumi Tagawa   +13 more
doaj   +1 more source

Sofosbuvir-velpatasvir en pacientes mexicanos con hepatitis C: una revisión retrospectiva

Revista de Gastroenterología de México, 2022
Resumen: Introducción: La combinación de sofosbuvir-velpatasvir (SOF/VEL) es una terapia antiviral de acción directa que está autorizada y disponible en México.
J.L. Pérez-Hernández, C.A. Arce-Salinas, R. Lehmann-Mendoza, A. Torre-Delgadillo, G.E. Castro-Narro, E. Cerda-Reyes, M.V. Ramos-Gómez, L. Juárez-Chavez, M. Dehesa-Violante, L.E. Muñoz-Espinosa, L.E. Cisneros-Garza, I. Aiza-Haddad, J.A. Velarde-Ruiz-Velasco, R. Contreras-Omaña, N. García-Casarreal, A. Carmona-Castañeda, F. Higuera-De la Tijera   +16 more
doaj   +1 more source

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC).
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn   +12 more
doaj   +1 more source

The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment [PDF]

Kosin Medical Journal, 2012
Objectives The combination therapy with peginterferon and ribavirin has been used to treat chronic hepatitis C for several years in Korea but there is a few report about the results of the treatment.
Dong Hyun Park, Sang Uk Lee, Jin Seok Yu, Jun Seop Lee, Hye Jung Kwon   +4 more
doaj   +1 more source

Letter: sustained virological response and liver healing – authors' reply [PDF]

Alimentary Pharmacology & Therapeutics, 2017
Linked ContentThis article is linked to Rossotti et al and Schwabl et al papers. To view these articles visit https://doi.org/10.1111/apt.13982 and https://doi.org/10.1111/apt.13844.
M. Mandorfer, P. Schwabl, M. Peck‐Radosavljevic, T. Reiberger   +3 more
openaire   +2 more sources

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea.
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon   +20 more
doaj   +1 more source

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature [PDF]

, 2019
The second-generation of direct-acting antiviral agents are the current treatment for chronic viral hepatitis C infection. To evaluate the regression of liver fibrosis in patients receiving this therapy, liver biopsy remains the most accurate method, but
Alexescu, Teodora G, Cibu, Bianca A, Ciulei, George, Coste, Sorina C, Cozma, Angela, Mureșan, Flaviu, Negrean, Vasile, Orasan, Olga H, Ovidiu, Fabian, Pfingstgraf, Iulia O, Popovici, Ionela E, Tarmure, Simina F, Taut, Adela V. S   +12 more
core   +3 more sources

Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3 [PDF]

, 2007
Background Patients infected with hepatitis C virus (HCV) genotype 2 or 3 have sustained virologic response rates of approximately 80% after receiving treatment with peginterferon and ribavirin for 24 weeks.
Bacon, Bruce R., Barange, Karl, Harley, Hugh, Lin, Amy, Nelson, David, Shafran, Stephen D., Shiffman, Mitchell L., Sola, Richard, Soman, Ash, Suter, Fredy, Zeuzem, Stefan   +10 more
core   +2 more sources

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Gastroenterology, 2019
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatocellular carcinoma (HCC). Despite effective antiviral therapies, the risk for HCC is decreased but not eliminated after a sustained virologic response (SVR)
Nourdine Hamdane, Frank Jühling, E. Crouchet, Houssein El Saghire, C. Thumann, Marine A. Oudot, S. Bandiera, Antonio Saviano, C. Ponsolles, A. A. Roca Suarez, Shen Li, N. Fujiwara, A. Ono, I. Davidson, N. Bardeesy, Christian Schmidl, C. Bock, C. Schuster, J. Lupberger, F. Habersetzer, M. Dofföel, T. Piardi, D. Sommacale, M. Imamura, Takuro Uchida, H. Ohdan, H. Aikata, K. Chayama, T. Boldanova, P. Pessaux, B. Fuchs, Y. Hoshida, M. Zeisel, F. Duong, T. Baumert   +34 more
semanticscholar   +1 more source